Abstract: Chronic kidney disease (CKD) causes alterations in thyroid hormones
I. Introduction
Chronic renal failure (CRF) is a world-wide serious health and economic issue with an increasing incidence and prevalence. The term chronic renal failure usually means the end stage of chronic kidney disease with a decline in glomerular filtration rate (GFR) below 0.25mL/sec. (Zadrazil, 2011). As kidney function declines, there is a progressive deterioration in mineral homeostasis and changes in circulating hormones Although the pathogenesis of hypothalamic-pituitary-thyroid axis abnormalities encountered in nonthyroidal illness (NTI) as CRF remains elusive, it is currently agreed that it may be related to increased cytokines production (Abozenah et al., 2008) .
Cytokines are small cell-signaling protein molecules that are secreted by numerous cells and are a category of signaling molecules used extensively in intercellular communication. Cytokines act as key communicators for immune cells and maintaining a delicate balance in the level of these communicators is vital for health-in many chronic diseases, this balance is disrupted (Hafler, 2007) . Interleukin-6 (IL-6) is a pleiotropic cytokine. IL-6 has been implicated in the generation and propagation of chronic inflammation. Initially in acute inflammation, proinflammatory cytokines promote neutrophil accumulation and the release of IL-6 (Barnes et al., 2011) .
In this study, we assess pituitary thyroid axis function in patients with chronic renal failure and its relation with serum Interleukin-6 concentration, in order to: estimate the potential use of thyroid hormones testing as morbidity indicator in patients with chronic renal failure and illustrate the potential link between thyroid function and Interleukin-6.
II.
Subjects and Methods
II.1 Subjects
This study included 90 subjects; 65 HD patients, their age range from 23 to 68 year with mean age 40.17± 12.58 year and with the average duration of dialysis 2.21 ± 0.12 years, they were 47 (72.3%) males and 18 (27.7%) females, all patients were undergoing dialysis treatment following diagnosis of end stage renal disease (ESRD) by nephrologists in the Urology and Nephrology Center, Mansoura University , hemodialysis unit ,each patient was dialyzed 3 times per week also, 25 healthy volunteers as normal control group their age range from 25 to 70 year with mean age 42.35 ± 14.03 ,they were 15(60%) male and 10(40%) female.The control subjects were collected from donner blood bank,Mansoura University. Serum creatinine , uric acid, blood urea nitrogen (BUN) and liver function parameters as, serum albumin ,total bilirubine,liver enzymes (SGPT , SGOT and ALP ) were tested. The control subjects had normal kidney functions, normal thyroid functions .They were free from any kidney diseases. The studied subjects(patients and controls) were in the same socioeconomic class and had similar nutritional habits.
II.2 Blood sample collection and examination
Five milliliters venous blood were collected using a disposable plastic syringe from each patient and healthy individuals.All samples of patients were collected before the dialysis ( pre-hemodialysis) One milliliter from 5 ml was collected on EDTA for evaluation of hemoglobin level. The rest of blood (4ml) were collected on free tubes without addition anticoaggulants ,were centrifuged at 3000 rpm for 5 minutes to obtain serum for estimation of interleukin-6 (IL-6) thyroid hormones (T3,T4 and TSH), kidney functions testes (creatinine ,BUN and uric acid ) and liver functions testes in ESRD patients and control subjects. Interleukin-6 (IL- 
II.3 Statistical analysis
Data were obtained using Statistical package for social Sciences (SPSS) version 19.0 software. Data were expressed as means ±standard deviation (SD) .Results of ESRD patients and control subjects were performed using chi-square analysis, independent t-test . Correlation between parameters was determined by pearson 's correlation coefficient coefficient (r) . Chi square and odds ratio were calculated with 95% confidence interval .A p-value less than 0.05 was considered statistically significant.
III. Results
As observed in table (1), there were no significant difference of age and body mass index (BMI) in ESRD patients when compared with control subjects. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly higher in ESRD patients than in control subjects, (p <0.001).On the other hand , level of hemoglobin was significantly lower in ESRD patients as compared to control subjects (P<0.001).
III.1 Demographic data
The demographic data of HD patients and control group are presented in Table (1) . 
III.2 Laboratory data
In The present study ,clinical parameters such as creatinine ,blood urea nitrogen (BUN) and uric acid were tested for end stage renal disease (ESRD) patients,(n=65), as well as control subjects (n=25). Table (2) shows the levels of creatinine , BUN and uric acid were significantly increased in ESRD patients when compared with control subjects (p<0.001). In table (2) biochemical parameters such as albumin, total protein (TP),alkaline phosphatase (ALP) enzyme ,total bilirubin (TB), alanine aminotransferase (ALT) enzyme, asparate aminotransferase (AST) enzyme, sodium, potassium, calcium, phosphorus, interleukin-6 (IL-6),total triiodothyronine (tT3) hormone, total thyroxine (tT4) hormone and thyroid -stimulating hormone (TSH) were tested for end stage renal disease (ESRD) patients,(n=65), as well as control subjects (n=25).The levels of albumin, TP, sodium, calcium, tT3 (p<0.001) and tT4 (p = 0.01) were low significant in ESRD patients when compared with control subjects, but the levels of ALP enzyme , potassium ,phosphorus and IL-6 were higher significant in ESRD patints than in control subjects.
On the other hand, the levels of ALT,AST enzymes, total bilirubin and TSH levels of ESRD were not significant compared with control subjects .
III.3 Analysis of correlation
As shown in table (3), concentration of serum interleukin-6 (IL-6) in ESRD patients revealed high significant negative correlation (p< 0.05) with total triiodothyronine hormone (tT3 ) (r=-0.767). Also, there was mild significant negative correlation (p<0.05 ) between IL -6 and total thyroxine hormone (tT4) in ESRD patients (r=-0.318 ) Figures (1 and 2) . The results showed that there was no significant correlation between interleukin -6 (IL-6) and thyroid stimulating hormone (TSH) in End Stage Renal Disease( ESRD) patients, n=65. 
IV. Discussion
Chronic kidney disease (CKD) is well -known cause of nonthyroidal iilness syndrom (NTIs) (i.e., altreation in thyroid hormones without underlying thyroid disorder) and affects all levels of the hypothalamuspituitary thyroid axis. The interpretion of thyroid functions in patients with CKD is even more complicated by the declination in glomerular filtration rate (GFR) ( Chopra, 1996 and Tarng, 2012). The interactions between kidney and thyroid functions are known for many years (Basu and Mohaptra , 2012). CKD affects thyroid function in multiple ways, including low levels of circulating thyroid hormone concentration ,altered peripheral hormone metabolism, disturbed binding to carrier proteins ,possible reduction in tissue of thyroid hormone content and increased iodine stores in the thyroid gland. Both serum triiodothyronine (T3) and total thyroxine (T4) levels are reduced (Alsaran et al ., 2011) . All the levels of hypothalamic-pituitary-thyroid axis involved alterations in hormone production and excretion,this was observed in pre-dialysis patients with CKD that had an increased risk of hypothyroidism (Lo et al ., 2005) .
Serum T3 levels were consistently found to be low ,serum T4 concentrations have been reported as low, normal or high ( Avasthi et al ., 2001 ) .The most common thyroid function abnormality in CKD is low T3 level (Kaptein , 1996 and Wiederkehr , 2004 ). Low T3 levels occurs in CKD due to several reasons .Fasting ,chronic metabolic acidosis and chronic protein malnutrition affect iodothyronine deiodation ,as well as protein binding of T3, reducing the peripheral convertion of T4 to T3 (Zoccali et al ., 2005) . Decreased T3 levels are not due to increased T3 degradation or to reduced thyroidal T3 secretion but is a result of impaired extrathyroidal T4 toT3 convertion, while thyroid gland production of T3 is normal (Singh et al ., 2006) . The reduction in T4 is attributed to the presence of circulating inhibtors, which impair binding of T4 to thyroxinbinding globulin. Despite decreased circulating T4 and T3 levels ,thyroid-stimulating hormone (TSH) levels were not elevated .This absence of elevated TSH levels is not due to dysfunction of the hypothalmo-pituitary axis , this confirmed that these patients were NTI (Alsaran et al ., 2011) .
Many studies have focused on the role of inflammatory cytokines which are known to be important mediators of CKD (Davies et al., 1996) .The concentration of several cytokines are elevated in patients with CKD due to their decreased renal clearance Previous reports were indicated a significant decrease in the level of serum triiodothyronine (T3)with normal level of thyroid stimulating hormone(TSH)as compared with healthy controls (song et al ., 2009) these were in aggrement with the presenet results.
In this study, we observed elevated levels of serum IL-6 when compared with control group as table (2) . A highly significant inverse correlation between IL-6 and T3 levels was estimated as in figuer (1) , this in accordance with (Lo et al .,2005) .Also, there was a mild negative correlation between serum IL-6 and total T4 levels as in figure (2) 
V. Conclusion
Prevalence of hypothyroidism disease in patients with NTIs increases with long-term hemodialysis According to this study, we found that low serum tT3 low serum tT4 levels and high level of IL-6.we suggest that thyroid hormone especially T3 measurements as useful morbidity indicator for CKD.
